GSK plc ( GSK) - Stock Earnings
GSK Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2026Q1 | 2.3 billion USD | 10.1 billion USD |
| 2026Q2 | 576.3 million USD | 11.1 billion USD |
| 2026Q3 | 2.0 billion USD | 11.7 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
GSK Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 6.3 billion USD | 38.6 billion USD |
| 2024 | 3.2 billion USD | 39.4 billion USD |
| 2025 | 7.7 billion USD | 43.9 billion USD |
| 2026 Est. | — | — |
GSK
Price: $48.26
Dividend Yield: 3.70%
Forward Dividend Yield: 3.78%
Payout Ratio: 52.47%
Dividend Per Share: 1.81 USD
Earnings Per Share: 2.87 USD
P/E Ratio: 17.12
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United Kingdom
Volume: 3.7 million
Ebitda: 2.0 billionMarket Capitalization: 98.4 billion
Average Dividend Frequency: 4
Years Paying Dividends: 43
DGR3: -1.69%
DGR5: -5.85%
DGR10: -4.42%
DGR20: 0.33%